Our Approach
Our innovative models disrupt the development paradigm by offering an aligned and efficient approach to develop late-stage therapies and accelerate approval. Learn more about these models below.
Proven and innovative research capabilities
Financing and development
Regulatory approval and commercialization
Proven and innovative research capabilities
Financing and development
Regulatory approval and commercialization
Value To Our Partners
Focus On What You Do Best - Science
You own the science. Launch Tx gives you the appropriate level of operational support. You can focus on developing other assets.
Nothing To Lose
If Phase 3 is unsuccessful – you lose nothing and continue to focus on other programs.
Access To Expertise
Gain access to a global network of dedicated resources across drug development, regulatory and commercialization leveraging best of Launch Tx, Carlyle, and Abingworth.
Innovative Partnering Models
Launch Tx Provides Operational Expertise Across a Spectrum of Clinical Co-Development Collaboration Models
We tailor the clinical co-development relationship to meet your operational needs
- Launch Tx serves in an advisory capacity
- E.g., Establish joint steering committee with members from Launch Tx and Partner to oversee trial
- Launch Tx provides some support and resources
- E.g., Launch Tx takes responsibility for select operational workstreams, while Partner maintains operational control of trial
- Launch Tx has full operational control of trial
- E.g., Launch Tx has responsibility for most or all workstreams through regulatory submission